Daiichi Sankyo Archives

AZ signs multi-billion cancer R&D deal with Daiichi Sankyo

https://pharmaphorum.com/news/az-signs-multi-billion-cancer-rd-deal-with-daiichi-sankyo/

Lixiana hits the mark in catheter ablation trial

https://pharmaphorum.com/news/lixiana-hits-the-mark-in-catheter-ablation-trial/

Daiichi gets speedy FDA review for rare cancer drug

https://pharmaphorum.com/news/daiichi-speedy-fda-review-rare-cancer-drug/

Daiichi Sankyo takes option on diabetes stem cell start-up

https://pharmaphorum.com/news/daiichi-sankyo-takes-option-on-diabetes-stem-cell-start-up/

Astellas scores first US blood cancer approval with Xospata

https://pharmaphorum.com/news/astellas-scores-first-us-blood-cancer-approval-with-xospata/

FDA grants leukaemia drug ‘breakthrough’ status

https://pharmaphorum.com/market-access-2/fda-grants-leukaemia-drug-breakthrough-status/

ASCO 2018 – Monday 4th June: BMS tries different tack as Merck & Co locks out lung cancer I/O

https://pharmaphorum.com/event-coverage/asco-2018-bms-merck-co-locks-out-lung-cancer-i-o/

AZ tried to buy Daiichi Sankyo last year – report

https://pharmaphorum.com/news/az-tried-buy-daiichi-sankyo-last-year-report/

Daiichi Sankyo anticoagulant gains EU label boost

https://pharmaphorum.com/news/daiichi-sankyo-noac-get-eu-label-boost/

Search